01
Oct
2019

Share

Why did Nufarm’s share price rally following its result?

The share price of agricultural chemical company Nufarm (ASX:NUF) increased 26 per cent on Monday following the release of its earnings results for the 12 months to July 2019. The company also announced the sale of its Latin American businesses to its major shareholder, Sumitomo.

The earnings results were largely in line with sell side analyst forecasts. However, market expectations had already been lowered significantly on the back of a string of trading updates throughout the year. Results for the year were well below what the company regards as ‘normal’ due to a combination of adverse weather conditions that took their toll on demand for the company’s products, and supply chain issues. Excluding the impact of acquisitions, EBITDA fell 2.4 per cent during the year, while the acquired portfolio of products in Europe delivered well below management’s expectations from the time of the acquisition a little over a year ago.

So why did the share price rally so significantly when the company at best met lowered market expectations?

The reason lies in the positioning of market participants leading into the result release. Despite the A$300 million equity raising undertaken by the company 12 months ago, the weak trading had resulted in increased balance sheet gearing. Due to high working capital requirements, the core agricultural chemicals businesses are capital intensive in nature.

When demand disappoints, it has multiple consequences including a negative impact on sales and inventory build from forward orders of inputs ahead of the selling season. The inventory build tends to lead to margin erosion as competitors look to sell excess stock. It also leads to higher than normal financial gearing as debt remains higher than normal post the purchase of seasonal stock requirements.

The increased risk of ongoing pressure on both earnings and gearing created a perception that more equity funding could be required in the near term. Those looking to benefit from such an outcome built short positions in the market that grew as the near-term outlook deteriorated with each successive trading update. By the time the result was released, over 20 per cent of the free float in the company’s stock had been shorted.

Screen Shot 2019-10-01 at 2.46.35 pm

Source: Bloomberg

The announcement of the sale of the Latin American operations to Sumitomo materially impacted the bear case for the stock. The price received for the business was above the value attributed to it by most sell side analysts.

Additionally, the proceeds received reduced the company’s net debt from 3.0x EBITDA to just 0.7x, shifting the risk from potentially having to raise equity, to a position of relative balance sheet flexibility with the possibility of capital management in the medium term. Lastly, it removed the most capital intensive, highest risk, and most exposed business to volatile currencies from the company’s portfolio.

The unwinding of the bear case has resulted in a short squeeze, driving the share price up as those with short positions rush to unwind their positions. Given average daily turnover in Nufarm of 3.3 million shares, and a short interest of 66.8 million shares as of 24 September, the aggregate short interest would take 4 weeks of trading to unwind even if every buy was from a short seller closing out their position. This is likely to see Nufarm’s share price remain well supported for some time.

My colleague Joseph wrote an article about short squeeze previously, click here to read it.

Our Funds

The Montgomery Fund

  • AUSTRALIA/NZ
  • Concentrated high conviction equities
  • From $25,000
Learn More

Montgomery Global Fund

  • GLOBAL
  • Concentrated high conviction equities
  • From $25,000
Learn More

Montgomery Alpha Plus Fund

  • GLOBAL
  • A market neutral strategy
  • From $50,000
Learn More

Montaka Global Access Fund

  • GLOBAL
  • Access long/short global equity portfolio
  • From $50,000
Learn More

Montgomery Global Equities Fund (ASX:MOGL)

  • GLOBAL
  • Concentrated high conviction equities
  • No minimum investment - see your broker limits
Learn More

Montgomery Small Companies Fund

  • AUSTRALIA/NZ
  • Concentrated high conviction equities
  • From $25,000
Learn More
Close

Our Funds

Concentrated High Conviction Equities

Listed

Montgomery Global Equities Fund (ASX:MOGL)

Global
Available on the ASX as an Exchange Traded Managed Fund, invests in 15 to 30 quality global businesses for long-term capital growth with a target distribution yield of 4.5% per annum. Mirrors the strategy of the Montgomery Global Fund.
Unlisted From $25,000

Montgomery Global Fund

Global
Invests in 15 to 30 quality global businesses for long-term capital growth. Priced daily. Mirrors the strategy of the Montgomery Global Equities Fund (ASX:MOGL).
Unlisted from $25,000

The Montgomery Fund

Australia/NZ
Aims to provide long-term growth and income by investing in 20 to 40 high-quality Australian and New Zealand businesses trading at attractive valuations. Priced daily.
New Fund

Montgomery Small Companies Fund

Australia/NZ
Aims to provide long-term growth by investing in 30 to 50 high quality, undervalued, Australian and NZ small and emerging companies with strong growth potential. Priced daily.
Unlisted from $1 Million

The Montgomery [Private] Fund

Australia/NZ
Seeks to deliver absolute returns from a portfolio of high-quality Australian and New Zealand businesses. Capital preservation is paramount. By invitation only.

Alternate Equity Strategies

Unlisted from $50,000

Montgomery Alpha Plus Fund

Global
Aims to generate positive returns in both rising and falling markets. Invests in 80 to 180 global businesses expected to deliver above-average returns, while selling short a similar-sized portfolio expected to deliver below-average returns. Priced daily.
Unlisted from $50,000

Montaka Global Access Fund

Global
Aims to generate materially higher risk-adjusted returns, net of fees, than is generally available in the equities market over the medium term. Priced monthly. Provides retail investors access to the Montaka Global Fund.
Unlisted From $1 Million

Montaka Global Fund

Global
Aims to generate materially higher risk-adjusted returns, net of fees, than is generally available in the equities market over the medium term. By invitation only.